{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:56:27Z","timestamp":1792652187591,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.vaccine.2020.08.016","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T10:54:16Z","timestamp":1617188056000},"page":"2736-2745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["The safety of BCG revaccination: A systematic review"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7507-3704","authenticated-orcid":false,"given":"Samantha","family":"Bannister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Sudbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Perrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9517","key":"10.1016\/j.vaccine.2020.08.016_b0005","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.08.016_b0010","unstructured":"The BCG World Atlas. 2017 [cited 2020 April 21]; 2nd."},{"issue":"8","key":"10.1016\/j.vaccine.2020.08.016_b0015","first-page":"73","article-title":"vaccines: WHO position paper - February 2018","volume":"93","author":"Anonymous","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2020.08.016_b0020","unstructured":"Evidence to recommendation table: Need to revaccination (Table 5). SAGE evidence to recommendations framework. WHO: Strategic Advisory Group of Experts (SAGE) on Immunization background papers; 2017."},{"issue":"2","key":"10.1016\/j.vaccine.2020.08.016_b0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2020.08.016_b0030","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/14656561003657145","article-title":"Intravesical therapy for bladder cancer","volume":"11","author":"Williams","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"10.1016\/j.vaccine.2020.08.016_b0035","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1586\/era.11.163","article-title":"Role of bacillus Calmette-Guerin in the treatment of advanced melanoma","volume":"11","author":"Stewart","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2020.08.016_b0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/INF.0b013e3182458289","article-title":"Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin vaccination at first health center contact","volume":"31","author":"Biering-Sorensen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.08.016_b0045","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2020.08.016_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2015-310282","article-title":"Non-specific effects of vaccines: plausible and potentially important, but implications uncertain","author":"Pollard","year":"2017","journal-title":"Arch Dis Child"},{"issue":"8","key":"10.1016\/j.vaccine.2020.08.016_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041756","article-title":"Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes","volume":"7","author":"Faustman","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.016_b0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/01.wnl.0000438216.93319.ab","article-title":"Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS","volume":"82","author":"Ristori","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.vaccine.2020.08.016_b0065","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/infdis\/jiy207","article-title":"Does BCG Vaccination Protect Against Nontuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis","volume":"218","author":"Zimmermann","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.016_b0070","doi-asserted-by":"crossref","unstructured":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet 1996;348(9019):17\u201324.","DOI":"10.1016\/S0140-6736(96)02166-6"},{"key":"10.1016\/j.vaccine.2020.08.016_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c671","article-title":"Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau","volume":"340","author":"Roth","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.vaccine.2020.08.016_b0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2020.08.016_b0085","first-page":"338","article-title":"The Karonga Prevention Trial: a leprosy and tuberculosis vaccine trial in northern Malawi. I. Methods of the vaccination phase","volume":"64","author":"Ponnighaus","year":"1993","journal-title":"Lepr Rev"},{"issue":"9493","key":"10.1016\/j.vaccine.2020.08.016_b0090","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2020.08.016_b0095","first-page":"399","article-title":"Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren","volume":"7","author":"Dourado","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2020.08.016_b0100","article-title":"BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial","volume":"2","author":"Cunha","year":"2008","journal-title":"PLoS Neglect Trop Dis [electronic resource]"},{"issue":"31","key":"10.1016\/j.vaccine.2020.08.016_b0105","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1016\/j.vaccine.2014.04.084","article-title":"Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults","volume":"32","author":"Hatherill","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.016_b0110","first-page":"63","article-title":"The immediate effects of BCG revaccination","volume":"41","author":"Nyboe","year":"1969","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.vaccine.2020.08.016_b0115","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1081-1206(10)61890-X","article-title":"Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial","volume":"88","author":"Choi","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.08.016_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175215","article-title":"Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901","volume":"12","author":"von Reyn","year":"2017","journal-title":"PLoS ONE"},{"issue":"24","key":"10.1016\/j.vaccine.2020.08.016_b0125","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130540","article-title":"BCG revaccination boosts adaptive polyfunctional Th1\/Th17 and innate effectors in IGRA+ and IGRA- Indian adults","volume":"4","author":"Rakshit","year":"2019","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.vaccine.2020.08.016_b0130","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/00365540701367777","article-title":"Primary vaccination and revaccination of young adults with BCG: a study using immunological markers","volume":"39","author":"Fjallbrant","year":"2007","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.016_b0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10156-004-0357-8","article-title":"Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production by PBMC in adults after BCG vaccination","volume":"11","author":"Nabeshima","year":"2005","journal-title":"J Infect Chemother"},{"issue":"11","key":"10.1016\/j.vaccine.2020.08.016_b0140","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1034\/j.1398-9995.2003.00246.x","article-title":"Effects of BCG revaccination on asthma","volume":"58","author":"Choi","year":"2003","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.vaccine.2020.08.016_b0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/338462","article-title":"National study of adverse reactions after vaccination with bacille Calmette-Guerin","volume":"34","author":"Turnbull","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2020.08.016_b0150","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-3016.1993.tb00408.x","article-title":"The decline of BCG immunity after neonatal vaccination: what about revaccination at one year?","volume":"7","author":"Aydinlioglu","year":"1993","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.08.016_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005934","article-title":"Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A","volume":"4","author":"Whelan","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.08.016_b0160","first-page":"107","article-title":"BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics","volume":"21","author":"Lotte","year":"1984","journal-title":"Adv Tuberc Res"},{"issue":"12","key":"10.1016\/j.vaccine.2020.08.016_b0165","first-page":"1110","article-title":"Adverse effects of BCG revaccination: a report on 13 cases from Rio de Janeiro, Brazil","volume":"6","author":"Cunha","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2020.08.016_b0170","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0151-9638(07)91603-8","article-title":"Adverse effects of BCG revaccination: 12 cases","volume":"134","author":"El Ouazzani","year":"2007","journal-title":"Ann Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.08.016_b0175","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4161\/hv.19067","article-title":"Cutaneous necrotic ulceration due to BCG re-vaccination","volume":"8","author":"Gyldenlove","year":"2012","journal-title":"Human Vacc Immunother"},{"issue":"12","key":"10.1016\/j.vaccine.2020.08.016_b0180","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0151-9638(04)93844-6","article-title":"A persistent ulceration after a fortuitous BCG revaccination","volume":"131","author":"Cuchet","year":"2004","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.016_b0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0041-3879(88)90043-8","article-title":"Sternal abscess as a complication of BCG-revaccination","volume":"69","author":"Simila","year":"1988","journal-title":"Tubercle"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2020.08.016_b0190","first-page":"123","article-title":"Severe disseminated BCG infection in an 8-year-old girl","volume":"63","author":"Yamanaka","year":"2000","journal-title":"Nagoya J Med Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2020.08.016_b0195","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette-Guerin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"7409","key":"10.1016\/j.vaccine.2020.08.016_b0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bmj.327.7409.243","article-title":"Tuberculin testing before BCG vaccination","volume":"327","author":"Bothamley","year":"2003","journal-title":"BMJ"},{"issue":"31","key":"10.1016\/j.vaccine.2020.08.016_b0205","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","article-title":"Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial","volume":"29","author":"Barreto","year":"2011","journal-title":"Vaccine"},{"issue":"4 Pt 1","key":"10.1016\/j.vaccine.2020.08.016_b0210","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/ajrccm.157.4.9706037","article-title":"Bacillus Calmette-Guerin revaccination questionable with low tuberculosis incidence","volume":"157","author":"Tala-Heikkila","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.vaccine.2020.08.016_b0215","first-page":"717","article-title":"Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong","volume":"5","author":"Leung","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.016_b0220","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S2214-109X(18)30474-1","article-title":"Global shortages of BCG vaccine and tuberculous meningitis in children","volume":"7","author":"du Preez","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"10236","key":"10.1016\/j.vaccine.2020.08.016_b0225","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.08.016_b0230","unstructured":"Bulletin of the World Health Organization 1995. World Health Organization, p. 805\u201310."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:54:34Z","timestamp":1759402474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20310471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":46,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0264410X20310471"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The safety of BCG revaccination: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}